Lantheus Holdings PE Ratio 2013-2024 | LNTH
Current and historical p/e ratio for Lantheus Holdings (LNTH) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lantheus Holdings PE ratio as of April 04, 2025 is 16.43.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Lantheus Holdings PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-04-04 | 90.92 | 20.81 | |
2024-12-31 | 89.46 | $4.37 | 20.47 |
2024-09-30 | 109.75 | $6.01 | 18.26 |
2024-06-30 | 80.29 | $6.10 | 13.16 |
2024-03-31 | 62.24 | $6.55 | 9.50 |
2023-12-31 | 62.00 | $4.64 | 13.36 |
2023-09-30 | 69.48 | $1.43 | 48.59 |
2023-06-30 | 83.92 | $0.41 | 204.68 |
2023-03-31 | 82.56 | $-0.31 | 0.00 |
2022-12-31 | 50.96 | $0.34 | 149.88 |
2022-09-30 | 70.33 | $1.49 | 47.20 |
2022-06-30 | 66.03 | $0.43 | 153.56 |
2022-03-31 | 55.31 | $-0.57 | 0.00 |
2021-12-31 | 28.89 | $-1.05 | 0.00 |
2021-09-30 | 25.68 | $-0.51 | 0.00 |
2021-06-30 | 27.64 | $-0.41 | 0.00 |
2021-03-31 | 21.37 | $-0.18 | 0.00 |
2020-12-31 | 13.49 | $-0.23 | 0.00 |
2020-09-30 | 12.67 | $0.08 | 158.38 |
2020-06-30 | 14.30 | $0.30 | 47.67 |
2020-03-31 | 12.76 | $0.62 | 20.58 |
2019-12-31 | 20.51 | $0.79 | 25.96 |
2019-09-30 | 25.07 | $0.87 | 28.81 |
2019-06-30 | 28.30 | $0.99 | 28.59 |
2019-03-31 | 24.48 | $1.08 | 22.67 |
2018-12-31 | 15.65 | $1.04 | 15.05 |
2018-09-30 | 14.95 | $3.17 | 4.72 |
2018-06-30 | 14.55 | $3.15 | 4.62 |
2018-03-31 | 15.90 | $3.25 | 4.89 |
2017-12-31 | 20.45 | $3.15 | 6.49 |
2017-09-30 | 17.80 | $0.81 | 21.98 |
2017-06-30 | 17.65 | $0.72 | 24.51 |
2017-03-31 | 12.50 | $0.61 | 20.49 |
2016-12-31 | 8.60 | $0.84 | 10.24 |
2016-09-30 | 8.28 | $0.84 | 9.86 |
2016-06-30 | 3.67 | $0.89 | 4.12 |
2016-03-31 | 1.89 | $-0.64 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $6.684B | $1.534B |
Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $230.058B | 28.41 |
Boston Scientific (BSX) | United States | $149.209B | 40.19 |
Stryker (SYK) | United States | $142.084B | 30.54 |
EssilorLuxottica (ESLOY) | France | $131.854B | 0.00 |
Medtronic (MDT) | Ireland | $115.249B | 16.83 |
Haleon (HLN) | United Kingdom | $46.488B | 26.39 |
Lonza Group Ag (LZAGY) | Switzerland | $44.527B | 0.00 |
GE HealthCare Technologies (GEHC) | United States | $36.909B | 17.98 |
Agilent Technologies (A) | United States | $33.351B | 22.03 |
ResMed (RMD) | United States | $32.876B | 25.32 |
Terumo (TRUMY) | Japan | $27.805B | 39.54 |
Koninklijke Philips (PHG) | Netherlands | $23.874B | 17.05 |
Zimmer Biomet Holdings (ZBH) | United States | $22.530B | 14.15 |
Insulet (PODD) | United States | $18.442B | 78.86 |
Baxter (BAX) | United States | $17.557B | 12.63 |
Sunny Optical Technology (SNPTF) | China | $12.864B | 0.00 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
Demant (WILYY) | Denmark | $8.048B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.822B | 23.62 |
Prestige Consumer Healthcare (PBH) | United States | $4.259B | 20.32 |
Perrigo (PRGO) | Ireland | $3.826B | 10.95 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
ICU Medical (ICUI) | United States | $3.405B | 29.11 |
Haemonetics (HAE) | United States | $3.193B | 15.02 |
Envista Holdings (NVST) | United States | $2.972B | 23.64 |
QuidelOrtho (QDEL) | United States | $2.359B | 19.76 |
GN Store Nord (GNNDY) | Denmark | $2.336B | 15.74 |
LeMaitre Vascular (LMAT) | United States | $1.893B | 43.25 |
Neogen (NEOG) | United States | $1.881B | 21.67 |
AtriCure (ATRC) | United States | $1.577B | 0.00 |
AdaptHealth (AHCO) | United States | $1.462B | 14.08 |
Kestra Medical Technologies (KMTS) | $1.234B | 0.00 | |
InMode (INMD) | Israel | $1.234B | 10.31 |
Green Thumb Industries (GTBIF) | United States | $1.233B | 19.37 |
BioLife Solutions (BLFS) | United States | $1.073B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.865B | 13.27 |
Evolus (EOLS) | United States | $0.765B | 0.00 |
Owens & Minor (OMI) | United States | $0.698B | 5.94 |
CeriBell (CBLL) | United States | $0.689B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.601B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.562B | 0.00 |
Valneva SE (VALN) | France | $0.545B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.478B | 20.71 |
Omeros (OMER) | United States | $0.476B | 0.00 |
Surmodics (SRDX) | United States | $0.436B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.433B | 0.00 |
SNDL (SNDL) | Canada | $0.371B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
ZimVie (ZIMV) | United States | $0.301B | 18.00 |
Viemed Healthcare (VMD) | United States | $0.288B | 26.00 |
Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
Cerus (CERS) | United States | $0.258B | 0.00 |
Quanterix (QTRX) | United States | $0.252B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.252B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.247B | 43.90 |
Verano Holdings (VRNOF) | United States | $0.233B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.184B | 14.19 |
Biote (BTMD) | United States | $0.182B | 4.16 |
Brainsway (BWAY) | Israel | $0.178B | 55.71 |
TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
High Tide (HITI) | Canada | $0.153B | 0.00 |
Canopy Growth (CGC) | Canada | $0.144B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.140B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.128B | 0.00 |
Jin Medical (ZJYL) | China | $0.116B | 0.00 |
FitLife Brands (FTLF) | United States | $0.112B | 13.99 |
Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
Fonar (FONR) | United States | $0.087B | 12.18 |
MacroGenics (MGNX) | United States | $0.080B | 0.00 |
Veru (VERU) | United States | $0.072B | 0.00 |
Zynex (ZYXI) | United States | $0.067B | 24.44 |
United Health Products (UEEC) | United States | $0.066B | 0.00 |
Exagen (XGN) | United States | $0.064B | 0.00 |
InterCure (INCR) | Israel | $0.064B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
Apyx Medical (APYX) | United States | $0.052B | 0.00 |
Modular Medical (MODD) | United States | $0.044B | 0.00 |
ImmuCell (ICCC) | United States | $0.043B | 0.00 |
United-Guardian (UG) | United States | $0.041B | 12.66 |
Rockwell Medical (RMTI) | United States | $0.038B | 56.50 |
Safety Shot (SHOT) | United States | $0.027B | 0.00 |
INLIF (INLF) | $0.021B | 0.00 | |
Nephros (NEPH) | United States | $0.018B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
Flora Growth (FLGC) | United States | $0.012B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
Agape ATP (ATPC) | $0.005B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |